The MATPharm Study team at Rhode Island Hospital seeks participants for a 3-month study to try out a new approach for providing medication care for people with opioid use disorder. The study compares usual care to a new care approach at a specialty community pharmacy.
OUD and Pharmacy | OUD Care Innovations
Over 18 -Prescribed buprenorphine/Suboxone or naltrexone/Vivitrol or are interested in starting buprenorphine/Suboxone -live in Rhode Island
2 visits with study team, 3 months
-receive medication treatment with buprenorphine/Suboxone or naltrexone/Vivitrol, either from the pharmacy or from their usual care provider
-meet in person or remotely with study staff at start and end of study (2 visits)
-call/text mid-point check-in